MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum (Q38183147)

30 August 2017

MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum (English)

1 reference

30 August 2017

0 references

Andrew G Chambers

1

1 reference

30 August 2017

Andrew J Percy

series ordinal

2

1 reference

30 August 2017

Romain Simon

series ordinal

3

1 reference

30 August 2017

Christoph H Borchers

series ordinal

4

1 reference

30 August 2017

29 January 2014

1 reference

Expert Review of Proteomics

30 August 2017

1 reference

30 August 2017

11

1 reference

30 August 2017

2

1 reference

30 August 2017

137-148

1 reference

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

30 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Proteoform: a single term describing protein complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

On the development of plasma protein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Options and considerations when selecting a quantitative proteomics strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Proteomics by mass spectrometry: approaches, advances, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

The cancer cell secretome: a good source for discovering biomarkers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Discovery of biomarkers for gastric cancer: a proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Advances in proteomic prostate cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Proteomics and the search for biomarkers for renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Recommendations for biomarker identification and qualification in clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

The evolving role of mass spectrometry in cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Protein microarrays and novel detection platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Recent advances in multiplex immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Targeted mass spectrometry approaches for protein biomarker verification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Selected reaction monitoring applied to proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Development of MRM-based assays for the absolute quantitation of plasma proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Isotope dilution strategies for absolute quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Absolute quantitation of proteins in human blood by multiplexed multiple reaction monitoring mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Review of software tools for design and analysis of large scale MRM proteomic datasets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

High-throughput generation of selected reaction-monitoring assays for proteins and proteomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Affinity prefractionation for MS-based plasma proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Characterization of the low molecular weight human serum proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Immuno-MALDI-TOF MS: new perspectives for clinical applications of mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Duplexed iMALDI for the detection of angiotensin I and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

A targeted proteomics-based pipeline for verification of biomarkers in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated α-fibrinogen in plasma for pancreatic cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Biological and methodical challenges of blood-based proteomics in the field of neurological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Implementation of liquid chromatography/mass spectrometry into the clinical laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Comparison of standard- and nano-flow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

A HUPO test sample study reveals common problems in mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Standardized protocols for quality control of MRM-based plasma proteomic workflows.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Method and platform standardization in MRM-based quantitative plasma proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Digging deeper into the field of the small cell lung cancer tumor marker ProGRP: a method for differentiation of its isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Immunocapture and LC-MS/MS for selective quantification and differentiation of the isozymes of the biomarker neuron-specific enolase in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Quantification of a proteotypic peptide from protein C inhibitor by liquid chromatography-free SISCAPA-MALDI mass spectrometry: application to identification of recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

A mass spectrometry-based plasma protein panel targeting the tumor microenvironment in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Deglycosylation and label-free quantitative LC-MALDI MS applied to efficient serum biomarker discovery of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

A Reagent Resource to Identify Proteins and Peptides of Interest for the Cancer Community: Table I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

Preanalytical Variables for Plasma and Serum Proteome Analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2014.877346

10.1586/14789450.2014.877346

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference